دورية أكاديمية

Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial

التفاصيل البيبلوغرافية
العنوان: Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
المؤلفون: Zhao, Li, Wang, Xiongbiao, Wang, Xuefen, Wang, Dexi, Li, Xiangyang, Peng, Yiqiang, Liang, Yongjie, Liu, Hua, Xiao, Zuke, Lv, Xiaoju, Wu, Shiman, Dai, Yuanrong, Huang, Yijiang, Hu, Zhenghong, Qiu, Chen, Li, Xi, Zhang, Suiyang, Li, Wenpu, Liu, Shuang, Shi, Yi, Xiong, Chang, Kuang, Jiulong, Xiu, Qingyu, Cui, Shehuai, Li, Jianguo, Lin, Qichang, Huang, Wenxiang, Wan, Yixin, Qimanguli, Shen, Ce, Xiao, Yi, Wu, Xiaoju, Chuang, Yin Ching, Perng, Wann Cherng, Tsao, Shih-Ming, Hsu, Jeng-Yuan, Wang, Chin-Chou, Wang, Jen-Hsien, Yeh, Pen-Fang, Lin, His-Hsun, Kuo, P.H., Lin, Ming-Shian, Su, Wei-Juin, Yuan, Jinyi, Mo, Biwen, Ma, Zhuang, Lv, Yuan, Cheng, Shih-Lung, Yang, Yanping, Tong, Zhaohui, Wu, Renguang, Sun, Shenghua, Cao, Zhaolong, Wu, Jufang, Zhu, Demei, Chang, Liwen, Zhang, Yingyuan
المصدر: In Journal of Microbiology, Immunology and Infection February 2019 52(1):35-44
قاعدة البيانات: ScienceDirect
الوصف
تدمد:16841182
DOI:10.1016/j.jmii.2017.07.011